Shiba M, Shimizu I, Yasuda M, Ii K, Ito S
Second Department of Internal Medicine, School of Medicine, University of Tokushima, Japan.
Liver. 1998 Jun;18(3):196-204. doi: 10.1111/j.1600-0676.1998.tb00150.x.
AIMS/BACKGROUND: We wished to clarify the mechanisms that account for the increase in hepatic collagen accumulation during hepatic fibrosis.
The gene expression of type I and type III procollagens and matrix metalloproteinase-1 (MMP-1) was measured by Northern blot analysis; immunolocalization of both types of collagen was estimated by indirect immunohistochemical assay; and the hepatic content of collagen and malondialdehyde (MDA), a product of lipid peroxidation, were assayed in hepatic fibrosis induced in rats with a single dose of dimethylnitrosamine (DMN).
During the experimental period, more type I procollagen mRNA was found than type III procollagen mRNA. The immunoreactive intensity of type I collagen was greater in necrotic areas near central veins 3 days after DMN treatment than it was on day 9, whereas the type III collagen immunodeposition for the latter period of the hepatic fibrosis was stronger than it was on day 3. As compared with controls, hepatic collagen content increased significantly after 3 days and continued, increasing gradually, as did type I and III procollagen mRNA levels. On day 14, fibrosis was greatest and both types of procollagen gene expression were at their highest, and type I and III procollagen mRNA levels and hepatic collagen content increased as the dosage of DMN was raised. MMP-1 mRNA levels increased early in hepatic fibrogenesis, and increased on day 14 when DMN dosages were low. Hepatic MDA levels increased rapidly for 3 days after DMN treatment, remaining significantly higher than control values and showing a significant increase even in response to low DMN doses on day 14.
Our results suggested that fibrotic liver collagen content may make its first notable increase due in part to the balance between type I collagen and MMP-1 expression rates. Also, lipid peroxidation may be important in the mechanism of hepatofibrogenesis.
目的/背景:我们希望阐明肝纤维化过程中肝脏胶原积累增加的机制。
通过Northern印迹分析检测I型和III型前胶原以及基质金属蛋白酶-1(MMP-1)的基因表达;通过间接免疫组织化学分析评估两种类型胶原的免疫定位;并在单剂量二甲基亚硝胺(DMN)诱导的大鼠肝纤维化中检测肝脏胶原和脂质过氧化产物丙二醛(MDA)的含量。
在实验期间,发现I型前胶原mRNA比III型前胶原mRNA多。DMN处理3天后,中央静脉附近坏死区域I型胶原的免疫反应强度比第9天更强,而肝纤维化后期III型胶原的免疫沉积比第3天更强。与对照组相比,3天后肝脏胶原含量显著增加,并持续逐渐增加,I型和III型前胶原mRNA水平也如此。在第14天,纤维化最严重,两种类型的前胶原基因表达均处于最高水平,并且随着DMN剂量的增加,I型和III型前胶原mRNA水平以及肝脏胶原含量增加。MMP-1 mRNA水平在肝纤维化早期升高,在第14天当DMN剂量较低时也升高。DMN处理后3天肝脏MDA水平迅速升高,仍显著高于对照值,并且即使在第14天对低剂量DMN也有显著增加。
我们的结果表明肝脏纤维化胶原含量可能部分由于I型胶原和MMP-1表达率之间的平衡而首次显著增加。此外,脂质过氧化在肝纤维化发生机制中可能很重要。